Do you know what phloem and the Münch hypothesis are about?

Long distance transport in plants occurs in sieve tubes of the phloem. The pressure flow hypothesis introduced by Ernst Münch in 1930 describes a mechanism of osmotically generated pressure differentials that are supposed to drive the movement of sugars and other solutes in the phloem, but this hypothesis has long faced major challenges. The key... Read more

Oxford Instruments Asylum Research Launches Its New Online European AFM Probe Store

14 February 2017 Oxford Instruments Asylum Research has launched its new European Atomic Force Microscopy (AFM) Probe Store—https://afmProbes.AsylumResearch.eu. The EU Probe Store serves customers in all of Europe, India and the Middle East, offering a complete range of probes for virtually all AFMs. Customers can shop for a wide range of probe models including probes... Read more

Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals

CHALFONT ST. GILES, UK and ISTANBUL, TURKEY– 2 February 2017 – Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. With this expanded capacity, Arven will support local healthcare needs by bringing biopharmaceuticals to the Turkish and surrounding markets faster, whilst... Read more

Smiths Group welcomes European Commission clearance for acquisition of Morpho Detection

19 Jan 2017 Smiths Group plc (“Smiths Group”) welcomes the European Commission’s clearance of the proposed acquisition of Morpho Detection. In order to secure approval in Phase I of the EU merger review process, Smiths Group proposed the divestment of Morpho Detection’s explosive trace detection (“Trace”) business. This divestment is conditional on the successful closing... Read more

GE Healthcare to commercialize Rapiscan® outside the US, Canada & Mexico for increased access to heart exams

CHALFONT ST. GILES, UK – 3 January, 2017 – GE Healthcare’s Life Sciences business announced today that it has acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan® (regadenoson) in territories outside the USA, Canada and Mexico. GE Healthcare’s strong industry presence and existing customer and... Read more

Molecular Devices Wins Patent Case In Europe

–Patent No. 1802752 “Parellel Patch Clamp System” Upheld in European Patent Office- Sunnyvale, California – October 7, 2016.   Molecular Devices, LLC, a company committed to providing innovative analytical solutions for protein and cell biology, announced today that its European Patent No. 1802752 titled “Parallel Patch Clamp System” was upheld by the European Patent Office in... Read more

GE Healthcare expands European capabilities to support accelerated biomanufacturing

CHALFONT ST. GILES, UK and PASCHING, AUSTRIA – 12 April 2016 – GE Healthcare’s Life Sciences business today announced that its European manufacturing and distribution site for sterile liquids has expanded its capabilities to include production of large volumes of buffers, process liquids and cell culture media, and launched a rapid production service for prototype... Read more

GE Analytical Instruments Expands Direct Operations into Italy

October 1, 2012 – Boulder, CO – GE Analytical Instruments announces the expansion of its direct European operations into Italy, effective June, 2012. This expansion is designed to better serve Sievers ultrapure water (UPW) and InnovOx total organic carbon (TOC) Analyzer customers by providing direct sales and applications support through local factory-trained staff. All GE Analytical... Read more